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The most important knowledge in the field of patient safety
is how to prevent harm to patients during treatment and care.
The fundamental role of patient safety reporting systems is to
enhance patient’s safety by learning from failures of the
health-care providers and system. If these failures are not
reported–or if serious side effects after medical interventions
are not reported–physicians all over the world will repeat the
same mistakes.
Therefore, publishing adverse events of a certain
treatment is one form of safety reporting system.
From critical incidence reporting systems (CIRS), we
know that most problems are not just a series of random,
unconnected on-off events, but are provoked by weak
systems and often have common root causes, which can be
generalized and corrected [1]. Although each event is unique,
there are likely to be similarities and patterns in sources of
risk that may otherwise go unnoticed if incidents are not
reported and analyzed. Ultimately, it is the action we take in
response to reporting–not reporting itself–that leads to
change.
Only few serious adverse events after the treatment using
bulking agents for urinary incontinence are reported; by the
way, there is a similar number of medlined papers on
serious vaginal trauma in jet-skiers. Does this mean that we
can neglect these side effects because there are so few?
Only five papers deal with serious vaginal trauma in jet-
skiers, but estimating the number of people who do jet ski,
there must be a couple of more accidents than those that are
reported. It might be similar for serious side effects of
bulking agents.
We probably dislike reporting complications and nega-
tive findings–in sports, because it is meant to be a fun
activity, in medicine because we want to offer successful
treatments to patients who expect to have their condition
improved.
Bulking agents have been approved by the Food and
Drug Administration (FDA) for use in women with intrinsic
sphincter deficiency and are generally seen as the most
minimally invasive surgical intervention with few side effects
[2]. Due to its minimal invasiveness, some authors do not
even consider this treatment as surgical but as belonging to
conservative treatment. From our own experience, we know
that the smaller the intervention is, the less preoperative
information is usually given to the patient.
Bulking agents have also been used off-label for the
treatment of stress urinary incontinence in men, especially
after radical retropubic prostatectomy in which incontinence
varies from 2.5% to 87% [3, 4].
A recent publication reports a 41% urethral erosion rate
in men who were injected with ethylene vinyl alcohol [5].
One patient suffered from extreme dysuria, urgency, and
frequency and required multiple follow-up visits and cysto-
scopic removal of the extruded material. Urethral erosion of
permanent injectable material is a scary condition and may
result in a drainpipe urethra with concomitant recurrent
infections, as well as deteriorating incontinence, which then
is difficult to treat. In another study using the samematerial for
the treatment of intrinsic sphincter deficiency in women, the
same group reported a 37% erosion rate in 19 patients, with 4
suffering from extreme pain and dysuria and finally 1
requiring repeat cystoscopy to remove the eroding material
[6].
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If there is a serious accident during jet-skiing including a
vaginal laceration even requiring ligation of an iliac artery
to save the patient’s life [7], the patients will probably tell
us “Had I only known before…!”
If patients are worse after treatment, it is painful and
sometimes dangerous for the patient, and stressful for the
surgeon. This patient might have the same feeling as the
unfortunate jet-skier.
Looking at the evidence in Medline and the Cochrane
Database [8], the benefit of bulking agents clearly over-
weighs the risks, but the latter may be underreported.
Periurethral mass formation after transurethral injection
has been described for most bulking agents; sterile abscesses
have been reported for carbon-coated zirconium-oxide
beads, collagen, and–more recently–hyaluronic acid, leading
to pain and secondary intervention. The current case in this
edition by Fatton et al. describes a prostate-like mass caused
by dextranomer microspheres in a cross-linked hyaluronic
acid vehicle leading to obstruction, which fortunately
resolved after drainage. The mechanism causing these sterile
abscesses to occur has not been explained so far; injection
technique, the substance itself, and underlying morbidities
have been discussed. Periurethral masses, which require
drainage, threaten continence, may result in urethral scar-
ring, and must be considered as a serious adverse event.
If voiding dysfunction occurs after bulking agents, the
possibility of periurethral mass formation needs to be
considered; we can only consider situations we know
about, and this is why we should encourage publishing
complications and negative study results.
Despite the minimalism of the intervention, the medical
community needs to know about these side effects because
information will influence product choice, and doctors are
obliged to inform the patient.
We act wrongly, Kant claims, when we treat people in
any way to which they cannot possibly consent [9]. On the
consent principle, it is wrong to treat patients in any way
they cannot rationally consent if they know the relevant facts
and we give them the power to choose how we treat them.
For jet-skiers, the relevant fact is probably that it is a fun
activity, which seldom leads to a serious health-threatening
accident.
In medicine, this is different. Information about potential
serious side effects of treatments must be given to the
patient. When surgical procedures or drugs are recommended
as off-label use, this status must be declared, and information
about unwanted effects should be explained and documented
thoroughly.
Injection therapy has been used sparingly for the manage-
ment of stress urinary incontinence for more than 2 decades,
but has been limited by antigenicity issues associated with
bovine collagen and durability of continence. Therefore,
bulking therapy has been less than optimal to date. For the
future, the goal of endoscopic injection therapy is to provide a
minimally invasive, safe, cost-effective, and durable alterna-
tive to open surgery.
Bulking agents can be used effectively and safely;
however, a few serious side effects do occur. Patients need
to be informed about this because otherwise they cannot
really consent.
In general, jet-skiers do know that they are prone to
accidents-only Essex girls need to be informed additionally
about serious vaginal trauma.
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